TickerFactsScreenerDevelopers

Theravance Biopharma, Inc. (TBPH) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $2.65M2016: $2.13M2017: $2.41M2018: $7.24M2019: $3.18M2020: $6.62M2021: $3.41M2022: $572.0K2023: $2.49M2024: $332.0K2025: $42.0K$42.0K
2015Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$42.0K-87.3%
2024$332.0K-86.7%
2023$2.49M+335.0%
2022$572.0K-83.2%
2021$3.41M-48.5%
2020$6.62M+108.3%
2019$3.18M-56.1%
2018$7.24M+200.9%
2017$2.41M+12.7%
2016$2.13M-19.3%
2015$2.65M—